Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-30 02:09:14 - browse：68

The corporate offices of Massachusetts General Brigham hospitals in Assembly Square in Somerville. Lane Turner/Globe Staff

The severing of ties between two of Boston’s biggest health care giants has placed one of the nation’s largest health care systems in the position of figuring out how, exactly, to fill a new hole in its oncology services, at a time when cancer care is changing rapidly.

Earlier this month, Dana-Farber Cancer Institute surprised the medical community and even its partner, Brigham and Women’s Hospital, when it announced that it would end their nearly 30-year collaboration. The split will take a few years to play out — Dana-Farber and Brigham and Women’s have a contract into 2028 — but has shaken patients and physicians.

Anne Klibanski, chief executive of Brigham and Women’s parent organization, Mass General Brigham, placed the blame on Dana-Farber executives. The two parties had been in discussions about extending their contract for months when the split was announced. “The decision was made by the Farber. It was announced. Now, we just have to plan forward,” she said. Klibanski shared her views on the split at a meeting with Boston Globe opinion editors on Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Steward Health Care expansion into Malta flopped

WSS

Cancer drug shortages' outsize impact on ovarian cancer patients

FDA approves first treatment for ultra

U.K. officials, researchers try to ease path for bespoke genetic treatments

Yancopoulos of Regeneron works to expand Dupixent success

Baltimore teen accused of firing into crowd during block party mass shooting

Medicare Advantage insurers pressure Biden for bigger payments

Wikipedia

Wikipedia

focus

Cancer drug shortages should be causing more outrage

New details revealed about Purdue's marketing of OxyContin

Hepatitis C has a cure — but many Americans still lack access to it

Cancer, immunology, HIV research ensnared in fetal tissue politics

What does generative AI mean for health care? We asked experts

New details revealed about Purdue's marketing of OxyContin

New air purifier tech could be key to improving indoor air quality

Mirador, a new biotech startup, launches with $400 million

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Biotech investment managers search for lucrative opportunities

hotspot

New definition of a human embryo proposed amid rapid advances

Hilary expected to bring catastrophic, life

As Maui death toll rises, number of missing remains unclear

Mirador, a new biotech startup, launches with $400 million

Listen: Racing for gene therapy & a pioneering approval

Chinese researcher claims birth of first gene

focus

Wikipedia

leisure time

knowledge